We observed that the AvL-EtOH-mediated inhibition of the β-catenin signaling pathway further decreases the mRNA expression of cyclin D1 and c-myc, thereby obstructing the growth and proliferation of human NSCLC cells. This evidence concerns the gene CCND1 and non-small cell lung carcinoma.